CN108815399A - 一种治疗中风的中药配方及其制备方法 - Google Patents
一种治疗中风的中药配方及其制备方法 Download PDFInfo
- Publication number
- CN108815399A CN108815399A CN201811046750.7A CN201811046750A CN108815399A CN 108815399 A CN108815399 A CN 108815399A CN 201811046750 A CN201811046750 A CN 201811046750A CN 108815399 A CN108815399 A CN 108815399A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- preparation
- radix
- treating apoplexy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 17
- 208000006011 Stroke Diseases 0.000 title claims abstract description 17
- 238000011282 treatment Methods 0.000 claims abstract description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 5
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 5
- 241000237636 Pheretima Species 0.000 claims abstract description 5
- 239000004615 ingredient Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 239000012530 fluid Substances 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 2
- 239000008280 blood Substances 0.000 claims description 25
- 210000004369 blood Anatomy 0.000 claims description 25
- 241000521581 Millettia Species 0.000 claims description 2
- 241000345998 Calamus manan Species 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 240000000249 Morus alba Species 0.000 claims 1
- 235000012950 rattan cane Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 5
- 210000004204 blood vessel Anatomy 0.000 description 14
- 208000007536 Thrombosis Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 206010019468 Hemiplegia Diseases 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 208000004929 Facial Paralysis Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010058483 Nuchal rigidity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000142 dyskinetic effect Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗中风的中药配方，按重量份数是包括以下中药成分：红花3g，山楂11g，赤芍11g，玉竹11g，路路通11g，地龙13g，当归13g，丹参16g。本发明中药组合物的制备和使用方法：先将药材用清水浸泡1小时，将药放在火上，用武火熬开，沸腾后改用文火煎煮50分钟，将药液倒出，每天1剂，分2次温服，14天为1个疗程。
Description
技术领域
本发明属于中药组合物，具体地说，是涉及一种用于中风治疗的中药配方及其制备方法。
背景技术
现代医学研究证明，血管中存在血栓才是中风真正的元凶，它像定时炸弹一样隐藏在血管中，其实从中青年开始每个人体内都存在一定数量的血栓，但因自身的溶栓能力比较强，发病率并不高；进入中老年之后，脑中风的发病率大大增高，原因是自身溶脂化栓能力随之下降，血脂易增高，血液变稠，血栓增多，居于大颗粒的血栓堵塞，脑血管的阻碍就造成脑供血、供氧不足，使脑细胞不同程度的受到损伤。
当脑部血管堵塞时，也会造成更多血栓，并且小血栓又会聚集成大血栓，但这些血栓若不即使溶解，长期在血中流动，可见血栓越多、越大，血压突然升高，使血管硬化，对生命的危害就越强。血栓又会沉积在血管内壁，日积月累使血管内径越来越狭窄，当血管被堵塞 50％时，早期症状不太明显，仅只是感到疲惫无力；当血管被堵塞超过70％时，中期症状明显出现头晕、头疼、胸闷、心悸、心律失常、心慌、心颤、四肢无力、记忆力下降，视力模糊、失眠多梦，高血压、高血糖等病接踵而来；当血管被堵塞超过80％时，晚期症状明显出现，四肢麻木、心肌缺血、心绞痛、冠心病、心肌梗塞、脑中风、老年痴呆等心脑血管疾病随之而来。若不及时治疗就会危及生命，致残、致死的机率随时都可能发生。因为当疲劳过度，放松休息时，血液流速变慢，此时血管弹性衰退，血栓障碍性越强，狭隘的血管就很容易被堵塞死，而堵塞了脑血管就形成中风、偏瘫；堵塞心血管就形成心肌梗塞；尤其是已经有了高血脂、高血压、心脏病等慢性心脑血管疾病的患者，表明患者的血管此时已经堵塞的非常 严重，所以不要只注重血脂的异常高低，而忽视血栓的存在。
脑梗塞危害极大，急性期死亡率为5％-15％，而且可导致脑部损害伴随着偏瘫失语、半身不遂、口眼歪斜等中风偏瘫的后遗症。如果能够及时救治，大部分人还是能够保住性命，但该病会由于各种诱因而随时复发，让人猝不及防，而复发后会加重病情，造成康复困难。实际上脑梗其本质还是血液问题沉积在血管壁上，血栓造成血管狭窄、动脉硬化，导致血液在 血管中流速缓慢，加重心脏负担，血液粘稠、混浊的血液供给营养的能力差，使心脏必然疲 惫不堪，病患接踵而来，使血管来增加流血量，更会使血管变硬、变脆容易痉挛，导致病情 越来越重，形成恶性循环。血管狭窄容易造成脑栓塞，动脉硬化，也会造成血管破裂，所以 血液粘稠、混浊是造成脑中风、偏瘫反复发作的根本原因。只有洗除血管垃圾、溶解大小血 栓颗粒，疏通脑血管，消除动脉硬化，并把粘稠、混浊的血液变清、变稀、畅通无阻，达到 康复目的。
病因：本病多发生在中老年，由于平素气血虚衰，心、肝、肾、三经阴阳失调，在情志郁结，暴饮暴食、房室劳累的影响下生火、动风、成痰、风火夹痰升腾，致使气血逆乱，如 血随气逆上充于脑，蒙蔽清窍，则突然昏迷不省人事，为邪中脏腑，如风痰走窜经络，致使 气血运行失调，则表现为口眼歪斜，半身不遂，为邪中经络，一般邪中脏腑的病例恢复后， 则遗留邪中，经络的病变。
现有治疗中风的西药起效快，药效强劲，但副作用大，抗药性大，这对于脑中风多为中老年患者来讲，西药会对肝肾造成一定的损伤。
发明内容
本发明的目的在于提供一种疗效好、见效快、无毒副作用的治疗脑中风后遗症的中药配方及制备方法。
为了实现上述发明目的，本发明制成该药物有效成分的原料组成及其重量配比为：红花3g，山楂11g，赤芍11g，玉竹11g，路路通11g，地龙13g，当归13g，丹参16g。
本发明中药组合物的制备和使用方法：先将药材用清水浸泡1小时，将药放在火上，用武火熬开，沸腾后改用文火煎煮50分钟，将药液倒出，每天1剂，分2次温服，14天为1个疗程。
发明用于治疗中风的中药配方，选择天然药物，针对中风病因病机，各味药材各具其效，互相协调，山楂、红花化瘀活血；赤芍活血凉血；丹参、当归活血养血；路路通通络祛风；地龙咸寒祛瘀活血；玉竹养阴增液以补血。
具体实施方式
实施例1：一种治疗中风的中药配方，按重量份数包括以下中药成分：红花3g，山楂11g，赤芍11g，玉竹11g，路路通11g，地龙13g，当归13g，丹参16g。
实施例2：如果患者血压偏高，在上述组分中加桑寄生11g，天麻13g。
实施例3：如果患者血压偏低，在上述组分中加川芎13g，升麻13g。
实施例4：如果患者手足麻木，在上述组分中加鸡血藤38g，牛大力38g。
先将药材用清水浸泡1小时，将药放在火上，用武火熬开，沸腾后改用文火煎煮50分钟，将药液倒出，每天1剂，分2次温服，14天为1个疗程。
以下通过实用例来阐明本发明所述用于中风护理的中药配方的临床治疗效果。
1、临床资料
对219例中风患者进行临床观察治疗， 年龄28～74岁。
2、疗效标准：疗效标准参照《中医病症判断疗效标准》中有关疗效标准
治愈：临床症状全部消失，实验室检查正常；
显效：临床症状基本消失，试验室检查各相关指标接近正常水平；
有效：临床症状减轻，试验室检查各相关指标有所改善，体征有改善；
无效：临床症状无明显好转或加重。
3、治疗结果
治疗效果：该临床观察病例中，服药3-5个疗程，临床治愈177例(80.82％)，显效28例(12.79％)，有效11例(5.02％)，无 效3例(1.37％)，总有效率为98.63％，中药品不良反应（ADR）评价，未发生不良反应和毒副作用。
典型案例：
史某，男76岁，突然昏倒，神志不清，不省人事，舌强言塞，牙关紧闭，两手紧握，痰声如锯，颈项强 直，手足重滞，肌肤不仁，手足麻木，口眼歪斜，口角涎沫，烦躁不安，肢体发凉，视力淡 漠，二便失禁，有时抽搐大有鼾声，两颊带红，面色苍白，心率不齐，脉弦滑等。T39.8℃， R38次/分，P128次/分，BP190/117mmHg，经医院CT检查，脑溢血，出血量60mt。症候分析：肢体抽搐，流窜经络，络脉空虚，风邪外袭，语言不利，肌肤不仁，痰迷心 窍，气血不畅，正气不足等。印象：祛风舒肝，肝阳暴张，阳元风动，气血上逆，活血通筋，神志不清，上扰清窍，热毒炽盛，潜阳熄风，呈瞌睡状等。症治：活血通筋，降低血脂，祛风通络，安神开窍，清窍醒脑，泻火退烧，解毒息风等。方剂：本发明配方，每日1剂，水煎服，分2次服用，早晚各1次。立法：降压清脑，通络活血。经治了两个疗程后，病情大为好转，能下床活动，行走灵活，语言清楚，继续中医调理， 疏通经络，调整阴阳，扶正祛邪，宣导气血，辟秽化浊，熄风止痉，祛瘀生新等治疗恢复自理。
Claims (5)
1.一种治疗中风的中药配方，其特征在于：该中药配方按重量份数包括以下中药成分：红花3g，山楂11g，赤芍11g，玉竹11g，路路通11g，地龙13g，当归13g，丹参16g。
2.如权利要求1所述的一种治疗中风的中药配方，其特征在于：该中药配方还包括桑寄生11g，天麻13g。
3.如权利要求1所述的一种治疗中风的中药配方，其特征在于：该中药配方还包括川芎13g，升麻13g。
4.如权利要求1所述的一种治疗中风的中药配方，其特征在于：该中药配方还包括鸡血藤38g，牛大力38g。
5.如权利要求1所述的一种治疗中风的中药配方的制备方法，其特征在于：先将药材用清水浸泡1小时，将药放在火上，用武火熬开，沸腾后改用文火煎煮50分钟，将药液倒出，每天1剂，分2次温服，14天为1个疗程。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811046750.7A CN108815399A (zh) | 2018-09-08 | 2018-09-08 | 一种治疗中风的中药配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811046750.7A CN108815399A (zh) | 2018-09-08 | 2018-09-08 | 一种治疗中风的中药配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108815399A true CN108815399A (zh) | 2018-11-16 |
Family
ID=64149137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811046750.7A Withdrawn CN108815399A (zh) | 2018-09-08 | 2018-09-08 | 一种治疗中风的中药配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108815399A (zh) |
-
2018
- 2018-09-08 CN CN201811046750.7A patent/CN108815399A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101391077A (zh) | 一种治疗慢性盆腔炎的中药制备方法 | |
| CN105770734A (zh) | 一种外用于治疗骨性关节炎关节酸痛症的中药组合物 | |
| CN104398982A (zh) | 一种治疗跌打损伤、关节肿痛的中药组合物 | |
| CN104013910A (zh) | 一种治疗高血压的中药组合物 | |
| CN108186749A (zh) | 治疗颈椎病的中药组合物及其制备方法 | |
| CN103933284A (zh) | 一种治疗风湿病的药液及其制备方法 | |
| CN104013836B (zh) | 一种治疗脑中风后遗症的中药组合物 | |
| CN102349957A (zh) | 一种治疗痒疹的中药组合物 | |
| CN102579623B (zh) | 一种治疗外伤型臁疮的中药洗剂制备方法 | |
| CN102824421B (zh) | 一种治疗惊惕型闭合性骨折的中药洗剂制备方法 | |
| CN108815399A (zh) | 一种治疗中风的中药配方及其制备方法 | |
| CN103356951B (zh) | 一种治疗心脏供血不足的中药组合物 | |
| CN103211911A (zh) | 一种治疗血栓闭塞性脉管炎的药物 | |
| CN103285360B (zh) | 一种治疗血栓闭塞性脉管炎的中药制剂及其制备方法 | |
| CN102973882A (zh) | 一种治疗颈椎病的中药 | |
| CN102764325B (zh) | 祛湿除痛中药组合物 | |
| CN102614479A (zh) | 一种治疗肾阳虚型臁疮的中药洗剂制备方法 | |
| CN102631633B (zh) | 一种治疗便秘型红丝疔的中药洗剂制备方法 | |
| CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
| CN103230553A (zh) | 一种治疗渗出型脓性指头炎的中药洗剂制备方法 | |
| CN102614437B (zh) | 一种治疗经久不敛型臁疮的中药洗剂制备方法 | |
| CN104161821A (zh) | 一种活血通络的中药擦剂 | |
| CN104147234A (zh) | 一种治疗颈肩腰腿痛的外用中药擦敷组合剂 | |
| CN102526687B (zh) | 一种治疗衣着欠缺型臁疮的中药洗剂制备方法 | |
| CN102671112A (zh) | 一种治疗瘀血型臁疮的中药制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181116 |
|
| WW01 | Invention patent application withdrawn after publication |